138 related articles for article (PubMed ID: 27562994)
1. [DNA aptamers selection for breast cancer].
Zamay GS; Belayanina IV; Zamay AS; Komarova MA; Krat AV; Eremina EN; Zukov RA; Sokolov AE; Zamay TN
Biomed Khim; 2016 May; 62(4):411-7. PubMed ID: 27562994
[TBL] [Abstract][Full Text] [Related]
2. Systematic evaluation of cell-SELEX enriched aptamers binding to breast cancer cells.
Civit L; Taghdisi SM; Jonczyk A; Haßel SK; Gröber C; Blank M; Stunden HJ; Beyer M; Schultze J; Latz E; Mayer G
Biochimie; 2018 Feb; 145():53-62. PubMed ID: 29054799
[TBL] [Abstract][Full Text] [Related]
3. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
[TBL] [Abstract][Full Text] [Related]
4. Identification of an aptamer targeting hnRNP A1 by tissue slide-based SELEX.
Li S; Xu H; Ding H; Huang Y; Cao X; Yang G; Li J; Xie Z; Meng Y; Li X; Zhao Q; Shen B; Shao N
J Pathol; 2009 Jul; 218(3):327-36. PubMed ID: 19291713
[TBL] [Abstract][Full Text] [Related]
5. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
[TBL] [Abstract][Full Text] [Related]
6. Generation of an enriched pool of DNA aptamers for an HER2-overexpressing cell line selected by Cell SELEX.
Dastjerdi K; Tabar GH; Dehghani H; Haghparast A
Biotechnol Appl Biochem; 2011; 58(4):226-30. PubMed ID: 21838796
[TBL] [Abstract][Full Text] [Related]
7. Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas.
Sett A; Borthakur BB; Bora U
Clin Transl Oncol; 2017 Aug; 19(8):976-988. PubMed ID: 28224267
[TBL] [Abstract][Full Text] [Related]
8. An Aptamer-Based Probe for Molecular Subtyping of Breast Cancer.
Liu M; Wang Z; Tan T; Chen Z; Mou X; Yu X; Deng Y; Lu G; He N
Theranostics; 2018; 8(20):5772-5783. PubMed ID: 30555580
[TBL] [Abstract][Full Text] [Related]
9. [Screening and characterization of DNA aptamers with hTNF-alpha binding and neutralizing activity].
Guo KT; Yan XR; Huang GJ; Xu CX; Chai YS; Zhang ZQ
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):730-3. PubMed ID: 15971588
[TBL] [Abstract][Full Text] [Related]
10. A novel molecular marker of breast cancer stem cells identified by cell-SELEX method.
Lu M; Zhou L; Zheng X; Quan Y; Wang X; Zhou X; Ren J
Cancer Biomark; 2015; 15(2):163-70. PubMed ID: 25519016
[TBL] [Abstract][Full Text] [Related]
11. Advances in Aptamers-Based Applications in Breast Cancer: Drug Delivery, Therapeutics, and Diagnostics.
Gholikhani T; Kumar S; Valizadeh H; Mahdinloo S; Adibkia K; Zakeri-Milani P; Barzegar-Jalali M; Jimenez B
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430951
[TBL] [Abstract][Full Text] [Related]
12. The DNA aptamer binds stemness-enriched cancer cells in pancreatic cancer.
Kim YJ; Lee HS; Jung DE; Kim JM; Song SY
J Mol Recognit; 2017 Apr; 30(4):. PubMed ID: 27891685
[TBL] [Abstract][Full Text] [Related]
13. Aptamer selection and applications for breast cancer diagnostics and therapy.
Liu M; Yu X; Chen Z; Yang T; Yang D; Liu Q; Du K; Li B; Wang Z; Li S; Deng Y; He N
J Nanobiotechnology; 2017 Nov; 15(1):81. PubMed ID: 29132385
[TBL] [Abstract][Full Text] [Related]
14. Selection of DNA aptamers with affinity for pro-gastrin-releasing peptide (proGRP), a tumor marker for small cell lung cancer.
Mie M; Kai T; Le T; Cass AE; Kobatake E
Appl Biochem Biotechnol; 2013 Jan; 169(1):250-5. PubMed ID: 23179274
[TBL] [Abstract][Full Text] [Related]
15. Aptamers: new arrows to target dendritic cells.
Ganji A; Varasteh A; Sankian M
J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of aptamer-target interactions by branched selection and high-throughput sequencing of SELEX pools.
Dupont DM; Larsen N; Jensen JK; Andreasen PA; Kjems J
Nucleic Acids Res; 2015 Dec; 43(21):e139. PubMed ID: 26163061
[TBL] [Abstract][Full Text] [Related]
17. In vitro selection of DNA aptamers for metastatic breast cancer cell recognition and tissue imaging.
Li X; Zhang W; Liu L; Zhu Z; Ouyang G; An Y; Zhao C; Yang CJ
Anal Chem; 2014 Jul; 86(13):6596-603. PubMed ID: 24892693
[TBL] [Abstract][Full Text] [Related]
18. Absolute quantification of cell-bound DNA aptamers during SELEX.
Avci-Adali M; Wilhelm N; Perle N; Stoll H; Schlensak C; Wendel HP
Nucleic Acid Ther; 2013 Apr; 23(2):125-30. PubMed ID: 23405949
[TBL] [Abstract][Full Text] [Related]
19. Application of aptamers for targeted therapeutics.
Ray P; Viles KD; Soule EE; Woodruff RS
Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):255-71. PubMed ID: 23563807
[TBL] [Abstract][Full Text] [Related]
20. Selection and characterization of DNA aptamers against VEGF165 with aptamer blotting method and its application.
Ikebukuro K; Hasegawa H; Sode K
Nucleic Acids Symp Ser (Oxf); 2007; (51):399-400. PubMed ID: 18029755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
